1. Home
  2. QSG vs ADCT Comparison

QSG vs ADCT Comparison

Compare QSG & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QSG
  • ADCT
  • Stock Information
  • Founded
  • QSG 2019
  • ADCT 2011
  • Country
  • QSG China
  • ADCT Switzerland
  • Employees
  • QSG N/A
  • ADCT N/A
  • Industry
  • QSG Other Consumer Services
  • ADCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • QSG Real Estate
  • ADCT Health Care
  • Exchange
  • QSG Nasdaq
  • ADCT Nasdaq
  • Market Cap
  • QSG 140.0M
  • ADCT 127.9M
  • IPO Year
  • QSG 2023
  • ADCT 2020
  • Fundamental
  • Price
  • QSG $6.68
  • ADCT $1.29
  • Analyst Decision
  • QSG
  • ADCT Strong Buy
  • Analyst Count
  • QSG 0
  • ADCT 5
  • Target Price
  • QSG N/A
  • ADCT $7.75
  • AVG Volume (30 Days)
  • QSG 408.0K
  • ADCT 242.8K
  • Earning Date
  • QSG 06-05-2025
  • ADCT 05-14-2025
  • Dividend Yield
  • QSG 2.95%
  • ADCT N/A
  • EPS Growth
  • QSG 101.59
  • ADCT N/A
  • EPS
  • QSG 1.04
  • ADCT N/A
  • Revenue
  • QSG $477,141,565.00
  • ADCT $70,837,000.00
  • Revenue This Year
  • QSG N/A
  • ADCT $6.82
  • Revenue Next Year
  • QSG $6.09
  • ADCT $18.56
  • P/E Ratio
  • QSG $6.32
  • ADCT N/A
  • Revenue Growth
  • QSG N/A
  • ADCT 1.84
  • 52 Week Low
  • QSG $1.47
  • ADCT $1.05
  • 52 Week High
  • QSG $7.96
  • ADCT $4.83
  • Technical
  • Relative Strength Index (RSI)
  • QSG 68.49
  • ADCT 46.06
  • Support Level
  • QSG $6.26
  • ADCT $1.23
  • Resistance Level
  • QSG $7.15
  • ADCT $1.49
  • Average True Range (ATR)
  • QSG 0.61
  • ADCT 0.08
  • MACD
  • QSG 0.10
  • ADCT 0.01
  • Stochastic Oscillator
  • QSG 92.10
  • ADCT 36.67

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: